Need Training?

Build a solid foundation in science, formulation and product development—find out more!

Most Popular in:

Patents

Email This Item! Print This Item!

Patent Picks—Sugar Sunscreen, UV Microcapsules, ‘Rugby Ball’ Particles and More

By: Rachel L. Grabenhofer
Posted: January 31, 2012

page 4 of 4

This invention describes a composition and method of improving the appearance of hyperpigmented spots and skin tone that consists of applying a safe and effective amount of a Laminaria saccharina extract to a hyperpigmented spot for a period of time sufficient to improve the appearance of the spot; and of applying a vitamin B3 skin tone agent to the skin surface for a period of time sufficient to improve skin tone.

Legume/vegetable compositions and methods for treating post-inflammatory hyperpigmentation
US Patent 8106094
Publication date: Jan. 31, 2012
Assignee: Johnson & Johnson Consumer Companies Inc.

This invention relates to methods and compositions for treating and ameliorating skin conditions including post-inflammatory hyperpigmentation (PIH). More particularly, this invention relates to compositions containing certain natural extracts, salicylic acid and natural or synthetic retinoids. Various approaches to treating acne, photodamage and other skin conditions have been attempted, including treatment with vitamin A acid, i.e., tretinoin, and natural retinoids or retinoid precursors such as vitamin A alcohol, i.e., retinol. However, according to the inventors, topical treatment with retinoids can be irritating to the skin. In addition, oral treatment with retinoids has been found to have teratogenic effects. Thus, it would be desirable to find a topical treatment for acne and PIH.

In accordance with this patent, the inventors developed compositions and methods for treating and ameliorating acne and PIH that contain salicylic acid, nondenatured plant extracts—preferably legume products and more preferably, soy products in fluid or solid form—and at least one natural or synthetic retinoid or retinol compound. The novel compositions were clinically proven to reduce PIH.